Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Lack of Schnurri-2 expression associates with reduced bone remodeling and osteopenia.

Saita Y, Takagi T, Kitahara K, Usui M, Miyazono K, Ezura Y, Nakashima K, Kurosawa H, Ishii S, Noda M.

J Biol Chem. 2007 Apr 27;282(17):12907-15. Epub 2007 Feb 20.

2.

Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts.

Hoshino A, Iimura T, Ueha S, Hanada S, Maruoka Y, Mayahara M, Suzuki K, Imai T, Ito M, Manome Y, Yasuhara M, Kirino T, Yamaguchi A, Matsushima K, Yamamoto K.

J Biol Chem. 2010 Sep 10;285(37):28826-37. doi: 10.1074/jbc.M109.099424. Epub 2010 Jun 22.

3.

Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.

Nakamura A, Ly C, Cipetić M, Sims NA, Vieusseux J, Kartsogiannis V, Bouralexis S, Saleh H, Zhou H, Price JT, Martin TJ, Ng KW, Gillespie MT, Quinn JM.

Bone. 2007 Feb;40(2):305-15. Epub 2006 Oct 13.

PMID:
17049328
4.

GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.

Lee MS, Kim HS, Yeon JT, Choi SW, Chun CH, Kwak HB, Oh J.

J Immunol. 2009 Sep 1;183(5):3390-9. doi: 10.4049/jimmunol.0804314. Epub 2009 Jul 29.

5.

Schnurri-2 controls BMP-dependent adipogenesis via interaction with Smad proteins.

Jin W, Takagi T, Kanesashi SN, Kurahashi T, Nomura T, Harada J, Ishii S.

Dev Cell. 2006 Apr;10(4):461-71.

6.

The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation.

Morinobu M, Nakamoto T, Hino K, Tsuji K, Shen ZJ, Nakashima K, Nifuji A, Yamamoto H, Hirai H, Noda M.

J Exp Med. 2005 Mar 21;201(6):961-70.

7.

Regulation of T helper type 2 cell differentiation by murine Schnurri-2.

Kimura MY, Hosokawa H, Yamashita M, Hasegawa A, Iwamura C, Watarai H, Taniguchi M, Takagi T, Ishii S, Nakayama T.

J Exp Med. 2005 Feb 7;201(3):397-408.

8.

Constitutive c-fos expression in osteoblastic MC3T3-E1 cells stimulates osteoclast maturation and osteoclastic bone resorption.

Kuroki Y, Shiozawa S, Sugimoto T, Kanatani M, Kaji H, Miyachi A, Chihara K.

Clin Exp Immunol. 1994 Mar;95(3):536-9.

9.

Murine Schnurri-2 is required for positive selection of thymocytes.

Takagi T, Harada J, Ishii S.

Nat Immunol. 2001 Nov;2(11):1048-53.

PMID:
11668343
10.

Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.

Wu JB, Fong YC, Tsai HY, Chen YF, Tsuzuki M, Tang CH.

Eur J Pharmacol. 2008 Jul 7;588(2-3):333-41. doi: 10.1016/j.ejphar.2008.04.030. Epub 2008 May 19.

PMID:
18495116
11.

Schnurri-2 deficiency counteracts against bone loss induced by ovariectomy.

Nagao M, Saita Y, Hanyu R, Hemmi H, Notomi T, Hayata T, Nakamoto T, Nakashima K, Kaneko K, Kurosawa H, Ishii S, Ezura Y, Noda M.

J Cell Physiol. 2011 Mar;226(3):573-8. doi: 10.1002/jcp.22521.

PMID:
21069746
12.

Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice.

Zhang Z, Welte T, Troiano N, Maher SE, Fu XY, Bothwell AL.

Biochem Biophys Res Commun. 2005 Mar 18;328(3):800-7.

PMID:
15694417
13.

Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss.

Kwak HB, Kim JY, Kim KJ, Choi MK, Kim JJ, Kim KM, Shin YI, Lee MS, Kim HS, Kim JW, Chun CH, Cho HJ, Hong GY, Juhng SK, Yoon KH, Park BH, Bae JM, Han JK, Oh J.

Biol Pharm Bull. 2009 Jul;32(7):1193-8.

14.

Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity.

Ikeda F, Nishimura R, Matsubara T, Hata K, Reddy SV, Yoneda T.

J Immunol. 2006 Aug 15;177(4):2384-90.

15.

Schnurri-2 mutant mice are hypersensitive to stress and hyperactive.

Takagi T, Jin W, Taya K, Watanabe G, Mori K, Ishii S.

Brain Res. 2006 Sep 7;1108(1):88-97. Epub 2006 Jul 11.

PMID:
16836985
16.

Constitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorption.

Ono N, Nakashima K, Schipani E, Hayata T, Ezura Y, Soma K, Kronenberg HM, Noda M.

J Biol Chem. 2007 Aug 31;282(35):25509-16. Epub 2007 May 11.

17.

Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.

Mohamed SG, Sugiyama E, Shinoda K, Taki H, Hounoki H, Abdel-Aziz HO, Maruyama M, Kobayashi M, Ogawa H, Miyahara T.

Bone. 2007 Oct;41(4):592-602. Epub 2007 Jun 13.

PMID:
17627913
19.

Expression of bone morphogenetic proteins and their receptors in the bone marrow megakaryocytes of GATA-1(low) mice: a possible role in osteosclerosis.

Garimella R, Kacena MA, Tague SE, Wang J, Horowitz MC, Anderson HC.

J Histochem Cytochem. 2007 Jul;55(7):745-52. Epub 2007 Mar 19.

PMID:
17371937
20.

Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis.

Elabd C, Basillais A, Beaupied H, Breuil V, Wagner N, Scheideler M, Zaragosi LE, Massiéra F, Lemichez E, Trajanoski Z, Carle G, Euller-Ziegler L, Ailhaud G, Benhamou CL, Dani C, Amri EZ.

Stem Cells. 2008 Sep;26(9):2399-407. doi: 10.1634/stemcells.2008-0127. Epub 2008 Jun 26.

Supplemental Content

Support Center